US Stock MarketDetailed Quotes

TCBP TC BioPharm

Watchlist

1.4200
+0.0700+5.19%

Close Apr 18 16:00 ET

4.54MMarket Cap-59P/E (TTM)

TC BioPharm Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

(Q3)Sep 30, 2021

(FY)Dec 31, 2020

(Q4)Dec 31, 2020

(FY)Dec 31, 2019

Total revenue

94.30%3.84M

0.00%1.98M

0.00%494.67K

494.66K

-42.26%1.98M

494.67K

3.43M

Operating revenue

--0

94.30%3.84M

0.00%1.98M

0.00%494.67K

--494.66K

-42.26%1.98M

--494.67K

--3.43M

Cost of revenue

Gross profit

Operating expense

-10.60%14.24M

72.03%15.93M

11.32%9.26M

33.78%2.82M

2.65M

-17.38%8.32M

2.11M

10.07M

Selling and administrative expenses

-22.41%6.47M

168.14%8.34M

40.88%3.11M

111.76%1.18M

--1.05M

-26.80%2.21M

--555.56K

--3.01M

-General and administrative expense

-22.41%6.47M

168.14%8.34M

40.88%3.11M

111.76%1.18M

--1.05M

-26.80%2.21M

--555.56K

--3.01M

Research and development costs

2.36%7.77M

23.32%7.59M

-7.83%6.16M

4.99%1.65M

--1.6M

-22.45%6.68M

--1.57M

--8.61M

Other operating expenses

----

98.88%-6.38K

96.83%-435

--0

63.54%-569.2K

---13.71K

---1.56M

Operating profit

-17.84%-14.24M

-65.97%-12.08M

-14.86%-7.28M

-44.12%-2.33M

-2.16M

4.54%-6.34M

-1.61M

-6.64M

Net non-operating interest income expense

98.77%-83.03K

-96.40%-6.75M

-1,081.49%-3.44M

-2,692.96%-1.92M

-1.15M

-14.80%-291.03K

-68.81K

-253.51K

Non-operating interest income

----

-96.79%33

-98.78%5

--7

-95.30%1.03K

--410

--21.9K

Non-operating interest expense

-98.77%83.03K

96.40%6.75M

1,077.33%3.44M

2,676.43%1.92M

--1.15M

6.05%292.06K

--69.22K

--275.41K

Other net income (expense)

-53.64%7.33M

470.60%15.8M

-4.26M

-271.35K

Gain on sale of security

-50.00%7.97M

473.89%15.94M

---4.26M

---271.35K

----

Other non- operating income (expenses)

-360.19%-645.85K

---140.34K

----

Income before tax

-130.61%-7M

79.75%-3.03M

-126.00%-14.98M

-168.52%-4.52M

-7.3M

3.83%-6.63M

-1.68M

-6.89M

Income tax

36.70%-1.09M

-22.20%-1.72M

-20.10%-1.41M

-71.04%-620.09K

-274.94K

-41.87%-1.17M

-362.54K

-826.07K

Net income

-349.68%-5.91M

90.32%-1.31M

-148.74%-13.58M

-195.27%-3.9M

-7.03M

10.05%-5.46M

-1.32M

-6.07M

Net income continuous Operations

-349.68%-5.91M

90.32%-1.31M

-148.74%-13.58M

-195.27%-3.9M

---7.03M

10.05%-5.46M

---1.32M

---6.07M

Minority interest income

Net income attributable to the parent company

-349.68%-5.91M

90.32%-1.31M

-148.74%-13.58M

-195.27%-3.9M

-7.03M

10.05%-5.46M

-1.32M

-6.07M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-349.68%-5.91M

90.32%-1.31M

-148.74%-13.58M

-195.27%-3.9M

-7.03M

10.05%-5.46M

-1.32M

-6.07M

Basic earnings per share

49.74%-19.2

94.50%-38.2

-257.03%-694.4918

-323.82%-199.5161

-359.5044

10.05%-194.5202

-47.076

-216.263

Diluted earnings per share

49.74%-19.2

94.50%-38.2

-257.03%-694.4918

-323.82%-199.5161

-359.5044

10.05%-194.5202

-47.076

-216.263

Dividend per share

Currency Unit

GBP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021	(Q3)Sep 30, 2021	(FY)Dec 31, 2020	(Q4)Dec 31, 2020	(FY)Dec 31, 2019
Total revenue	0	94.30%3.84M	0.00%1.98M	0.00%494.67K	494.66K	-42.26%1.98M	494.67K	3.43M
Operating revenue	--0	94.30%3.84M	0.00%1.98M	0.00%494.67K	--494.66K	-42.26%1.98M	--494.67K	--3.43M
Cost of revenue
Gross profit
Operating expense	-10.60%14.24M	72.03%15.93M	11.32%9.26M	33.78%2.82M	2.65M	-17.38%8.32M	2.11M	10.07M
Selling and administrative expenses	-22.41%6.47M	168.14%8.34M	40.88%3.11M	111.76%1.18M	--1.05M	-26.80%2.21M	--555.56K	--3.01M
-General and administrative expense	-22.41%6.47M	168.14%8.34M	40.88%3.11M	111.76%1.18M	--1.05M	-26.80%2.21M	--555.56K	--3.01M
Research and development costs	2.36%7.77M	23.32%7.59M	-7.83%6.16M	4.99%1.65M	--1.6M	-22.45%6.68M	--1.57M	--8.61M
Other operating expenses	----	----	98.88%-6.38K	96.83%-435	--0	63.54%-569.2K	---13.71K	---1.56M
Operating profit	-17.84%-14.24M	-65.97%-12.08M	-14.86%-7.28M	-44.12%-2.33M	-2.16M	4.54%-6.34M	-1.61M	-6.64M
Net non-operating interest income expense	98.77%-83.03K	-96.40%-6.75M	-1,081.49%-3.44M	-2,692.96%-1.92M	-1.15M	-14.80%-291.03K	-68.81K	-253.51K
Non-operating interest income	----	----	-96.79%33	-98.78%5	--7	-95.30%1.03K	--410	--21.9K
Non-operating interest expense	-98.77%83.03K	96.40%6.75M	1,077.33%3.44M	2,676.43%1.92M	--1.15M	6.05%292.06K	--69.22K	--275.41K
Other net income (expense)	-53.64%7.33M	470.60%15.8M	-4.26M	-271.35K
Gain on sale of security	-50.00%7.97M	473.89%15.94M	---4.26M	---271.35K	----	----	----	----
Other non- operating income (expenses)	-360.19%-645.85K	---140.34K	----	----	----	----	----	----
Income before tax	-130.61%-7M	79.75%-3.03M	-126.00%-14.98M	-168.52%-4.52M	-7.3M	3.83%-6.63M	-1.68M	-6.89M
Income tax	36.70%-1.09M	-22.20%-1.72M	-20.10%-1.41M	-71.04%-620.09K	-274.94K	-41.87%-1.17M	-362.54K	-826.07K
Net income	-349.68%-5.91M	90.32%-1.31M	-148.74%-13.58M	-195.27%-3.9M	-7.03M	10.05%-5.46M	-1.32M	-6.07M
Net income continuous Operations	-349.68%-5.91M	90.32%-1.31M	-148.74%-13.58M	-195.27%-3.9M	---7.03M	10.05%-5.46M	---1.32M	---6.07M
Minority interest income
Net income attributable to the parent company	-349.68%-5.91M	90.32%-1.31M	-148.74%-13.58M	-195.27%-3.9M	-7.03M	10.05%-5.46M	-1.32M	-6.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-349.68%-5.91M	90.32%-1.31M	-148.74%-13.58M	-195.27%-3.9M	-7.03M	10.05%-5.46M	-1.32M	-6.07M
Basic earnings per share	49.74%-19.2	94.50%-38.2	-257.03%-694.4918	-323.82%-199.5161	-359.5044	10.05%-194.5202	-47.076	-216.263
Diluted earnings per share	49.74%-19.2	94.50%-38.2	-257.03%-694.4918	-323.82%-199.5161	-359.5044	10.05%-194.5202	-47.076	-216.263
Dividend per share
Currency Unit	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP
Audit Opinions	Unqualified Opinion with Explanatory Notes	Unqualified Opinion with Explanatory Notes	Unqualified Opinion with Explanatory Notes	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall